z-logo
open-access-imgOpen Access
The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis
Author(s) -
D. Prieto-Peña,
Sara RemuzgoMartínez,
J. Gonzalo OcejoVinyals,
Belén AtienzaMateo,
Fernanda Genre,
Alejandro Muñoz-Jiménez,
F. Ortíz-Sanjuán,
Susana Romero-Yuste,
C. Moriano,
E. Galíndez-Agirregoikoa,
I. Calvo,
Norberto OrtegoCenteno,
Noelia Álvarez-Rivas,
José A. MirandaFilloy,
Irene Llorente,
Javier Garcı́a-Garcı́a,
Ricardo Blanco,
Oreste Gualillo,
Javier Martı́n,
Santos Castañeda,
Raquel LópezMejías,
Miguel Á. GonzálezGay
Publication year - 2021
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/nn15lt
Subject(s) - medicine , giant cell arteritis , vasculitis , allele , human leukocyte antigen , pathology , biopsy , gastroenterology , immunology , biology , disease , antigen , genetics , gene
To determine if patients with the predominant extracranial large-vessel-vasculitis (LVV) pattern of giant cell arteritis (GCA) have a distinctive HLA-B association, different from that reported in biopsy-proven cranial GCA patients. In a further step we assessed if the combination of HLA-B and HLA-DRB1 alleles confers an increased risk for GCA susceptibility, either for the cranial and extracranial LVV phenotypes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom